Insecticides (India) Q1 2026 Profit Jumps 62.4%, Board Appointments Made

AGRICULTURE
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Insecticides (India) Q1 2026 Profit Jumps 62.4%, Board Appointments Made
Overview

Insecticides (India) reported a 62.43% sequential increase in profit to ₹14.36 crore for the March 2026 quarter. The company also announced board appointments, an employee stock scheme, and the dissolution of an overseas subsidiary.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Insecticides (India) Ltd Reports Strong Sequential Profit Growth

Insecticides (India) Ltd's profit for the quarter ended March 31, 2026, surged by 62.43% to ₹14.36 crore, compared to ₹8.84 crore in the previous quarter.

Reader Takeaway: Sequential profit growth and clean audit are positive; succession planning is a watch point.

What just happened

Insecticides (India) Limited announced its standalone financial results for the quarter ended March 31, 2026. Revenue from operations increased by 11.58% sequentially to ₹427.96 crore. Profit for the period saw a significant jump of 62.43%, reaching ₹14.36 crore from ₹8.84 crore in the prior quarter. The company also reported an unmodified auditor opinion.

Why this matters

The sequential profit growth indicates improving operational efficiency in the short term. The clean auditor opinion provides assurance to investors regarding financial reporting. The appointment of new directors and an employee stock scheme are aimed at strengthening governance and incentivizing employees for long-term commitment.

The backstory

Insecticides (India) Limited is a player in the agrochemical sector. The company has been focused on expanding its product portfolio and market reach. This results update follows previous filings related to its operational performance and corporate actions.

What changes now

Mr. Sanskar Aggarwal has been appointed as a Whole Time Director, and Mr. Atul Kumar as Vice President-Sales (North), effective May 28, 2026. The formulation of the 'IIL ESPS Scheme 2026' aims to retain talent. The dissolution of the Dubai-based subsidiary, IIL Overseas DMCC, signals a move towards operational streamlining.

Risks to watch

Investors will be watching the succession planning closely, particularly the appointment of Mr. Sanskar Aggarwal, who is related to the Managing Director. The effectiveness of the new leadership and the ESPS scheme in driving future performance will be key.

Peer comparison

As of the latest filings, Insecticides (India) Ltd operates in the agrochemical sector. Key peers include UPL Limited, Rallis India Ltd, and PI Industries Ltd. Sequential profit growth is a positive indicator within the industry, although specific peer financial data for the same period would be needed for a direct comparison.

Context metrics (time-bound)

For the quarter ended March 31, 2026, Insecticides (India) reported revenue of ₹427.96 crore and profit of ₹14.36 crore. This compares to ₹383.56 crore revenue and ₹8.84 crore profit for the quarter ended December 31, 2025.

What to track next

Investors should monitor the Annual General Meeting (AGM) scheduled for August 2026 for further strategic discussions. The performance of the newly appointed management and the impact of the ESPS scheme on equity capital will be crucial to track.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.